TIS tissue therapies limited
Add to My Watchlist 0.00% ! 0.0¢

disappointing, page-7

  1. ppeter
    136 Posts.
    clock Created with Sketch.
    19/08/12
    20:52
    Post #: 10590407
    rescourced I believe you are unrealistic in your comments on sm. I was CEO of a small R and D company and suprise suprise one does not have control over all things: sometimes very few. I think TIS will become another COH in time. The current delays appear to be of BSIs making and they are hurting patients, management and shareholders




    TIS Price at posting: 39.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Mandalay Resources Discovers High-Grade Skarn and Provides Update on Near Mine Exploration at Björkdal
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.